ICN PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 7248
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 495
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 1137
 
 
 
C07D HETEROCYCLIC COMPOUNDS 1161
 
 
 
C08K USE OF INORGANIC OR NON-MACROMOLECULAR ORGANIC SUBSTANCES AS COMPOUNDING INGREDIENTS 1101

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
6479463 Purine L-nucleosides, analogs and uses thereofJun 16, 00Nov 12, 02[A61K]
6211201 Multivalent salts of pyridostigmine and related compoundsJun 29, 99Apr 03, 01[A61K, C07D, C07C]
6150337 Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytesSep 18, 98Nov 21, 00[A61K, C07H]
6110453 Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using sameJan 26, 98Aug 29, 00[A01N, C08K]
6063772 Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytesJun 15, 98May 16, 00[A61K, C07H]
5767097 Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytesJan 23, 96Jun 16, 98[A61K, C07H]
5763419 Treatment of malignant tumors with 8-chloroadenosine 3',5'-cyclic monophasphateMay 10, 95Jun 09, 98[A61K, C07H]
5599546 Medicinal facial maskAug 19, 93Feb 04, 97[A61K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
6613896 Method of producing tiazofurin and other C-nucleosidesExpiredJun 06, 00Sep 02, 03[C07H]
6191266 Sugar modified nucleosidesExpiredDec 16, 96Feb 20, 01[C07H]
6017898 Inhibition of tumor growth by antisense oligonucleotides for IL-8 and IL-8 receptorExpiredApr 06, 98Jan 25, 00[A61K, C07H]
5907036 Procedures for obtaining ribo-C-nucleosidesExpiredFeb 20, 96May 25, 99[C07H]
5798250 Facilitating hepatitus virus infection in cell culture using a membrane stressorExpiredApr 15, 96Aug 25, 98[C12N]
5405837 Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirinExpiredMay 18, 93Apr 11, 95[A61K]
5089503 Temperature stable 5-fluorouracil compositionsExpiredSep 20, 89Feb 18, 92[A61K]
4853388 Method for treating psoriasis with cytotoxic agentsExpiredMay 15, 87Aug 01, 89[A61K]
4849426 Method for treating actinic keratosis with cytotoxic agentsExpiredDec 02, 87Jul 18, 89[A61K]
4820711 Method for treating actinic keratosis with cytotoxic agentsExpiredMay 15, 87Apr 11, 89[A61K]
4594414 2-.beta.-D-ribofuranosylselenazole-4-carboxamide compounds and methods for their productionExpiredJun 22, 84Jun 10, 86[C07H]
4594416 2-.beta.-D-ribofuranosylselenazole-4-carboxamide compounds and methods for their productionExpiredJul 23, 84Jun 10, 86[C07H]
4432975 Process for introducing vitamin B-12 into the bloodstreamExpiredOct 19, 81Feb 21, 84[A61K]
4328336 9-(.beta.-D-Ribofurandsyl)purine-6-carboxamide and related compoundsExpiredAug 26, 80May 04, 82[C07H]
4246408 Imidazo[1,2-a]-s-triazineExpiredMar 08, 79Jan 20, 81[C07D]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.